You searched for "Endophthalmitis"
Don’t ignore the black lesion! It might be mucormycosis
1 June 2017
| Tina Parmar
|
EYE - Cornea
Keeping mucormycosis infection in the foreground of your differential diagnosis, especially in those more vulnerable patients, will help save their lives if recognised and managed appropriately. Mucormycosis is a fulminant infection caused by the fungi of the family Mucoraceae. It...
The approach to trabeculectomy postoperative complications
1 August 2016
| Kaivon Pakzad-Vaezi
|
EYE - Glaucoma
Performing a trabeculectomy is like giving birth to a baby. It may be traumatic and there is scope for devastating error but once the operation is completed only then does the real work begin. The bleb must be nurtured into...
Celebrating eight years of the nurse-led intravitreal injection service
4 February 2021
| Adam Mapani, Robin Hamilton, Jonah Nago, Gavin Kissoondeeal, Bhavin Maru, Musa Sanyang, Rankin Pacheco, Helen Carpenter, Julie Sharma, Mary Masih, Tracy Luckett, Kate Falkner
|
EYE - Vitreo-Retinal, EYE - General
Moorfields Eye Hospital NHS Foundation Trust in London celebrated the eighth year of its nurse-led intravitreal (IVT) injection service in 2020. In collaboration with Beaver-Visitec International (BVI), Moorfields’ comprehensive one-day course for non-medical staff has blossomed into a thriving success....
The implementation of postoperative day 1 vitrectomy telephone follow-up consultations
In this pre-COVID-19 study, the authors argue that some follow-up consultations can be done by telephone without compromising patient safety. Thirty years ago, a study by Isernhagen et al. [1] found that 52% of patients required some form of unexpected...Managing an outreach eye service… 8000 miles away!
3 October 2024
| Rebecca Turner, Hannah Owen-Smith, Jonathan H Norris, Paul Rosen, Mandy Heathman, Becky Edwards
|
EYE - General
In 1997, Paul Rosen, a relatively newly appointed consultant surgeon to the Oxford Eye Hospital, was approached by Richard Davies, a GP in Stanley, Falkland Islands, to assist in the provision and management of the Falkland Islands eye surgery service....
The role of injection assistant devices in establishing a nurse-led AMD service
1 April 2018
| Hani Hasan
|
EYE - Vitreo-Retinal
The author shares his experience of setting up a nurse-led service to deliver anti-VEGF intravitreal injections and how injection assistant devices supported training. Age-related macular degeneration (AMD) has become a leading cause of irreversible blindness [1]. It is estimated that...
What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...
Complications with porous orbital implant after enucleation in retinoblastoma patients
1 April 2019
| Rina Bhatt
|
EYE - Orbit
This is a retrospective, case control study aimed to identify risk factors associated with complications in retinoblastoma patients following primary and secondary enucleations with porous implant placements. Patients with retinoblastoma who underwent enucleation with porous orbital implant placement between January...
Retroauricular myoperiosteal auto graft for orbital implant exposure
In this retrospective, observational study authors reviewed 27 eyes of 27 anophthalmic patients with implant exposure who had received a retroauricular myoperiosteal graft. Their main outcome measure was long-term coverage of implant and the secondary outcome was rate of post-surgical...
Features of branchio-oculo-facial syndrome
Branchio-oculo-facial (BOF) syndrome is an autosomal dominant inherited syndrome that typically presents with branchial cleft sinus defects, ocular anomalies and dysmorphic facial appearance. The authors present a new case alongside the results of a literature review describing the common genetic...Intravitreal injections delivered by ophthalmic clinical nurse specialists
1 June 2015
| Rita McLauchlan, D Armstrong, Konstantinos Balaskas, Sajjad Mahmood
|
EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...
Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service
4 August 2021
| Jane Ashworth, Tsveta Ivanova, Susmito Biswas, Assad Jalil, Georgina Hall, Rebecca Redmond, Graeme CM Black (Prof), William Newman, Neil Parry, Jane CB Gray, Charlotte Skitterall
|
EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...
